[1] Bernier V, Klein O.  Late effects of craniospinal irradiation for medulloblastomas in paediatric patients[J]. Neurochirurgie, 2021, 67(1): 83-86.   doi: 10.1016/j.neuchi.2018.01.006
[2] 杨美玲, 黎静, 李志强, 等.  螺旋断层放疗与常规放疗在全脑全脊髓照射中的剂量学比较[J]. 临床肿瘤学杂志, 2014, 19(8): 718-722.
Yang ML, Li J, Li ZQ, et al.  Dosimetric comparison between helical tomotherapy and conventional radiotherapy for craniospinal irradiation[J]. Chin Clin Oncol, 2014, 19(8): 718-722.
[3]

Romero-Expósito M, Toma-Dasu I, Dasu A. Determining out-of-field doses and second cancer risk from proton therapy in young patients-an overview[J/OL]. Front Oncol, 2022, 12: 892078[2022-06-26]. https://www.frontiersin.org/articles/10.3389/fonc.2022.892078/full. DOI: 10.3389/fonc.2022.892078.
[4] Balasubramanian S, Shobana MK.  Pediatric craniospinal irradiation-the implementation and use of normal tissue complication probability in comparing photon versus proton planning[J]. J Med Phys, 2021, 46(4): 244-252.   doi: 10.4103/jmp.jmp_75_21
[5] 黎静, 李志强, 文婷, 等.  螺旋断层放疗技术进行全中枢照射急性毒副反应的初步观察[J]. 中国微侵袭神经外科杂志, 2013, 18(2): 72-74.   doi: 10.11850/j.issn.1009-122X.2013.02.009
Li J, Li ZQ, Wen T, et al.  Observation of acute toxicity of craniospinal irradiation by helical tomotherapy[J]. Chin J Minimally Invasive Neurosurg, 2013, 18(2): 72-74.   doi: 10.11850/j.issn.1009-122X.2013.02.009
[6] Majer M, Ambrožová I, Davídková M, et al.  Out-of-field doses in pediatric craniospinal irradiations with 3D-CRT, VMAT, and scanning proton radiotherapy: a phantom study[J]. Med Phys, 2022, 49(4): 2672-2683.   doi: 10.1002/mp.15493
[7] 杨美玲, 黎静, 李志强, 等.  螺旋断层放疗与常规放疗在全脑全脊髓放疗中的急性血液学毒性比较[J]. 肿瘤防治研究, 2014, 41(11): 1215-.   doi: 10.3971/j.issn.1000-8578.2014.11.012
Yang ML, Li J, Li ZQ, et al.  Acute haematological toxicity for patients treated with craniospinal irradiation: helical tomotherapy versus conventional radiotherapy[J]. Cancer Res Prev Treat, 2014, 41(11): 1215-.   doi: 10.3971/j.issn.1000-8578.2014.11.012
[8] Napieralska A, Brąclik I, Radwan M, Mandera M, Blamek S.  Radiosurgery or hypofractionated stereotactic radiotherapy after craniospinal irradiation in children and adults with medulloblastoma and ependymoma[J]. Childs Nerv Syst, 2019, 35(2): 267-275.   doi: 10.1007/s00381-018-4010-8
[9]

U.S. Department of Health and Human Services, National Institutes of Health National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0[EB/OL].(2009-05-28)[2021-11-02]. https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf.
[10] Robinson GW, Rudneva VA, Buchhalter I, et al.  Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial[J]. Lancet Oncol, 2018, 19(6): 768-784.   doi: 10.1016/S1470-2045(18)30204-3
[11]

Seidel C, Heider S, Hau P, et al. Radiotherapy in medulloblastoma-evolution of treatment, current concepts and future perspectives[J/OL]. Cancers (Basel), 2021, 13(23): 5945[2022-06-26]. https://www.mdpi.com/2072-6694/13/23/5945. DOI: 10.3390/cancers13235945.
[12] Aldrich KD, Horne VE, Bielamowicz K, et al.  Comparison of hypothyroidism, growth hormone deficiency, and adrenal insufficiency following proton and photon radiotherapy in children with medulloblastoma[J]. J Neurooncol, 2021, 155(1): 93-100.   doi: 10.1007/s11060-021-03847-y
[13]

Minturn JE, Mochizuki AY, Partap S, et al. A pilot study of low-dose craniospinal irradiation in patients with newly diagnosed average-risk medulloblastoma[J/OL]. Front Oncol, 2021, 11: 744739[2021-11-02]. https://www.frontiersin.org/articles/10.3389/fonc.2021.744739/full. DOI: 10.3389/fonc.2021.744739.
[14] 滕开原, 吴君心, 邵凌东.  全脑全脊髓放疗34例急性血液学毒性分析[J]. 基层医学论坛, 2016, 20(25): 3501-3503.   doi: 10.19435/j.1672-1721.2016.25.022
Teng KY, Wu JX, Shao LD.  Analysis of acute hematological toxicity in 34 cases of craniospinal irradiation[J]. Forum Primary Med, 2016, 20(25): 3501-3503.   doi: 10.19435/j.1672-1721.2016.25.022
[15] Jefferies S, Rajan B, Ashley S, et al.  Haematological toxicity of cranio-spinal irradiation[J]. Radiother Oncol, 1998, 48(1): 23-27.   doi: 10.1016/s0167-8140(98)00024-3
[16] 常浩, 于得全, 余宗艳, 等.  调强放射治疗技术用于全脑全脊髓放射治疗的可行性研究[J]. 生物医学工程与临床, 2021, 25(2): 184-189.   doi: 10.13339/j.cnki.sglc.20210226.007
Chang H, Yu DQ, Yu ZY, et al.  Feasibility analysis of optimize craniospinal irradiation with intensity-modulated radiation techniques[J]. Biomed Eng Clin Med, 2021, 25(2): 184-189.   doi: 10.13339/j.cnki.sglc.20210226.007
[17]

张俸萁. Helical TOMO therapy与IMRT治疗儿童髓母细胞瘤的剂量学比较和疗效评价[D]. 郑州: 郑州大学, 2020. DOI: 10.27466/d.cnki.gzzdu.2020.003497.

Zhang FQ. Efficacy evaluation and dose comparison of helical TOMO therapy and IMRT for Pediatric Medulloblastoma[D]. Zhengzhou: Zhengzhou University, 2020. DOI: 10.27466/d.cnki.gzzdu.2020.003497.
[18] Mell LK, Kochanski JD, Roeske JC, et al.  Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy[J]. Int J Radiat Oncol Biol Phys, 2006, 66(5): 1356-1365.   doi: 10.1016/j.ijrobp.2006.03.018
[19] Zhou PX, Zhang Y, Luo SG, et al.  Pelvic bone marrow sparing radiotherapy for cervical cancer: a systematic review and meta-analysis[J]. Radiother Oncol, 2021, 165: 103-118.   doi: 10.1016/j.radonc.2021.10.015
[20] Albuquerque K, Giangreco D, Morrison C, et al.  Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT[J]. Int J Radiat Oncol Biol Phys, 2011, 79(4): 1043-1047.   doi: 10.1016/j.ijrobp.2009.12.025